Q6P179 (ERAP2_HUMAN) Homo sapiens (Human)

Endoplasmic reticulum aminopeptidase 2 UniProtKBInterProSTRINGInteractive Modelling

960 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

11 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide ((1R)-1-Amino…homo-2-mer48-960
NAG;NAG;NAG;NAG;7OO;EDO;IMD;ZN;
Assess
Crystal structure of ERAP2 aminopeptidase in complex with phosphinic pseudotripeptide((1R)-1-Amino-…monomer50-960
NAG;NAG;NAG;62S;NAG;PEG;PGE;MES;EDO;PDO;IMD;ZN;
Assess
ERAP2 bound to Aryl Sulfonamide Uncompetitive Inhibitormonomer53-960
NAG;NAG;ZN;MES;J2G;LYS;NAG;
Assess
Crystal structure of Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) in complex with a hydroxamic de…monomer53-960
NAG;NAG;ZN;NAG;6GA;
Assess
Crystal structure of aminopeptidase ERAP2 with ligandmonomer54-960
NAG;NAG;ZN;NAG;EDO;MES;
Assess
Crystal structure of aminopeptidase ERAP2 with ligandmonomer54-960
NAG;NAG;NAG;ZN;EDO;
Assess
Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 in complex with PHOSPHINIC PS…monomer54-960
NAG;NAG;ZN;P52;IMD;
Assess
Crystal structure of Endoplasmic Reticulum aminopeptidase 2 (ERAP2) in complex with a diaminobenzoi…monomer54-960
NAG;ZN;6PX;NAG;
Assess
Crystal structure of ERAP2 without catalytic Zn(II) atommonomer54-960
NAG;NAG;NAG;
Assess
Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2monomer54-960
NAG;ZN;LYS;NAG;MES;
Assess
Crystal structure of the human Endoplasmic Reticulum Aminopeptidase 2 variant N392Kmonomer54-960
NAG;LYS;NAG;MES;ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7p7p.1.Amonomer0.9050-960
62S;IMD;ZN;99.90
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27pfs.1.Amonomer0.8848-525
ZN;99.62
Assess
Isoform 37p7p.1.Amonomer0.9050-915
62S;PDO;IMD;ZN;99.89
Assess
Isoform 47pfs.1.Ahomo-2-mer0.8748-342
NAG;94.44
Assess